2022
DOI: 10.1002/advs.202105285
|View full text |Cite
|
Sign up to set email alerts
|

Predicting Cardiovascular Stent Complications Using Self‐Reporting Biosensors for Noninvasive Detection of Disease

Abstract: Self‐reporting implantable medical devices are the future of cardiovascular healthcare. Cardiovascular complications such as blocked arteries that lead to the majority of heart attacks and strokes are frequently treated with inert metal stents that reopen affected vessels. Stents frequently re‐block after deployment due to a wound response called in‐stent restenosis (ISR). Herein, an implantable miniaturized sensor and telemetry system are developed that can detect this process, discern the different cell type… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 50 publications
0
15
0
Order By: Relevance
“…The wireless impedance electronics were adapted from our previously described circuitry 37 . The design was modified to include a 32-channel multiplexer to the electrodes, these were split into two banks A and B of 8 electrodes.…”
Section: Methodsmentioning
confidence: 99%
“…The wireless impedance electronics were adapted from our previously described circuitry 37 . The design was modified to include a 32-channel multiplexer to the electrodes, these were split into two banks A and B of 8 electrodes.…”
Section: Methodsmentioning
confidence: 99%
“…Electrochemical Sensing. Electrochemical sensing of biological samples is an area of high interest, with techniques like cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS) routinely used to assess parameters such as cell growth 73 or binding affinity. With more research groups now having access to micro/nano fabrication facilities, there has been a rapid increase in the type and number of electrochemical devices created, particularly in the field of wearable health trackers.…”
Section: ■ Emerging Biosensing Platforms Relevant For Cortisol Measur...mentioning
confidence: 99%
“…Previously, our work has addressed the issues mentioned earlier in SMART stent technology and sensors [11,16,17]. However, a series of technical barriers exist in developing SMART AVGs, such as sensor design for discerning different cell types associated with stenosis and thrombosis can cause issues while battery capacity and lifespan also pose problems.…”
Section: Introductionmentioning
confidence: 98%
“…Therefore, this could allow the clinician to intervene early, possibly extending the length of the AVGs life, which in turn could to better patient outcomes. Pertinent 'smart vascular implants', such as selfreporting stents incorporating biosensors and telemetry systems, can detect cell growth, blood pressure, and blood flow in vessels leading the way for a new generation of vascular intervention devices [11][12][13][14][15]. We, therefore, believe this technology is also amenable to arteriovenous grafts, which offer the potential for precision diagnosis and preemptive treatment for CKD patients.…”
Section: Introductionmentioning
confidence: 99%